Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway

Shigeki Saito(Tulane University), Joseph A. Lasky(Tulane University)
PLoS ONE
October 18, 2017
Cited by 115


Related Papers